March 10, 2020 / 7:50 AM / 19 days ago

BRIEF-DiaSorin Completes Studies For Launch Of Rapid Response Molecular Test For Covid-19

March 10 (Reuters) - DiaSorin SpA:

* COMPLETED THE STUDIES TO SUPPORT THE LAUNCH BY THE END OF MARCH 2020 OF A RAPID RESPONSE MOLECULAR DIAGNOSTIC TEST FOR THE CURRENT NOVEL CORONAVIRUS (COVID-19)

* PRODUCT EXPECTED TO BE LAUNCHED IN EUROPE CE MARKED AND SUBMITTED TO FDA UNDER EMERGENCY USE AUTHORIZATION PROCESS BY END OF MARCH 2020

* TEST IS DESIGNED FOR THE LIAISON® MDX INSTRUMENT USING ITS DIRECT AMPLIFICATION DISC TECHNOLOGY (DAD)

* TEST TO ENABLE SAMPLE-TO-ANSWER RESULTS WITHIN 60 MINUTES COMPARED TO 5-7 HOURS CURRENTLY NECESSARY TO REPORT PATIENT RESULTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below